IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer
PHASE3This is a randomized, multicenter, open-label, phase 3 study evaluating the...
Location
Chinese Academy of Medical Sciences and Peking Union Medical College
A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors
PHASE1This is a Phase 1/2, open-label, multicenter study designed to evaluate the...
Location
Scientia Clinical Research Ltd
Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
PHASE3This is a multiregional, multicenter, randomized, open-label, phase III stu...
Location
Affiliated Cancer Hospital of Chongqing University